Hamilton Insurance Group, Ltd. research snapshot
HG AI stock analysis currently reads Hamilton Insurance Group as a well-capitalized Bermuda-based specialty insurer and reinsurer operating through Hamilton Global Specialty, Hamilton Select, and Hamilton Re. At the August 3, 2026 cutoff, HG traded near $35.48 with a verified $3.52 billion market capitalization and a trailing P/E of about 5.8x. The company generated about $2.89 billion of trailing revenue and $629 million of trailing net income with a 21.7% profit margin and a 33.7% ROE. With about $1.29 billion of cash, only 5% debt-to-equity, $908 million of free cash flow, and a 52-week range of $21.01 to $37.31, the HG AI stock forecast depends on underwriting margins, premium growth, investment returns, and catastrophe loss activity. Hamilton paid a $2.00 special dividend in March 2026 and reports second quarter results on August 6, 2026. This page is informational research and not investment advice.
Current price
$35.48 intraday on August 3, 2026; prior close $35.96
Market cap
$3.52 billion
AI score
70 / 100
Rating
Well-capitalized Bermuda specialty insurer with strong ROE, low leverage, a new special dividend, and a low P/E that still prices in underwriting-cycle risk
Trend status
Uptrend intact near the 52-week high, above the 50-day and 200-day moving averages, with RSI no longer overbought
Data cutoff (updated monthly)
August 4, 2026
Informational use only. This page is not investment advice.
| Dimension | Conclusion | Confidence |
|---|---|---|
| Business quality | Hamilton Insurance operates three platforms that write specialty insurance and reinsurance across casualty, property, and specialty lines including accident and health, cyber, energy, financial lines, marine, and professional liability. | Medium-high |
| Moat | The moat comes from Bermuda licensing, underwriting expertise in specialty lines, broker relationships, and a clean balance sheet. The moat is narrower than large peers because HG has a shorter track record, smaller scale, and less brand recognition. AM Best upgraded Hamilton Select to A (Excellent) in May 2026. | Medium |
| Management | CEO Pina Albo has led the company since its 2013 founding, built three platforms, took the company public in 2023, and in early 2026 delivered a $200 million special dividend plus share repurchases. The key test is disciplined premium growth without relaxing underwriting standards in a softer pricing market. | Medium |
| Financial trend | Trailing revenue of $2.89 billion, trailing net income of $629 million, profit margin of 21.7%, ROE of about 33.7%, and free cash flow of $908 million. Q1 2026 delivered a 89.8% combined ratio, well below the 111.6% from the year-ago quarter. Balance sheet carries very low debt at about 5% debt-to-equity. | High |
| Valuation | At $35.48, verified math shows about 5.82x trailing P/E, 1.29x book value, 1.19x revenue, 3.88x free cash flow, and a 17% earnings yield. The valuation appears low on trailing numbers, which may reflect a forecast earnings decline for 2026 and cycle risk rather than an undiscovered bargain. | High |
| Technical trend | Price near $35.48 sits just below the 52-week high of $37.31 with a 52-week gain of about 69.5%, above the 50-day moving average of $33.03 and the 200-day moving average of $29.62. RSI near 58 is no longer overbought after the recent pullback. | Medium |
| Risk level | Key risks include catastrophe loss exposure, softer reinsurance pricing through the 2026 renewals, investment portfolio losses, reserve development, Middle East conflict losses in specialty lines, key-person risk in the 600-person organization, and share dilution from growth investments. | Medium-high |
| AI confidence | High for the trailing financial and valuation data. Lower for the forward view because smaller specialty insurers can experience large earnings swings from individual events or market segments, and the August 6, 2026 earnings release is still ahead. | High data confidence |
| Investment certainty | HG trades at a low single-digit earnings multiple with strong ROE, low debt, a $2.00 special dividend already paid, and $159 million of buyback capacity left, but the low P/E may partly reflect expected earnings normalization and a narrower business line base than larger peers. | Medium-low |
HG AI stock forecast
The HG AI stock forecast uses three-year scenario sensitivity, not a single target price. Starting from $6.10 of trailing EPS, the framework applies different growth and valuation assumptions. It is a scenario exercise, not a prediction, and it sits near a $35.86 average analyst target and a $39 median analyst target as of the August 3, 2026 cutoff.
$45 to $52
More likely if HG sustains high-teens to 20%+ ROE, keeps gross premiums written growing at high single to double digits, maintains combined ratios in the 80s, avoids large catastrophe losses, and the market re-rates trailing earnings toward 7x.
$35 to $42
More likely if HG holds earnings near recent levels, combined ratios stay moderately profitable, investment income stays stable, share repurchases continue, and the P/E remains near 6x. This zone overlaps the analyst median target of $39.
$20 to $27
More likely if HG suffers elevated catastrophe or conflict losses, reinsurance pricing softens further across key lines, reserves require strengthening, investment returns decline, and the P/E compresses toward 4x on normalized earnings.
HG AI technical analysis
HG AI technical analysis shows a strong uptrend through late July 2026 with price near the 52-week high. The 52-week range from $21.01 to $37.31 and a 52-week price gain of about 69.5% reflect strong underwriting results and shareholder returns. RSI near 58 indicates the momentum cooled from overbought levels, so support tests are possible without breaking the larger trend.
| Level | Value | Why it matters |
|---|---|---|
| Current price | $35.48 | StockAnalysis.com quote on August 3, 2026 intraday, with a prior close of $35.96. Used for market-cap and valuation math at the August 3, 2026 cutoff. |
| Near support | $33 to $35 | The 50-day moving average of $33.03 and the $35 breakout zone from earlier July form the first support band on a pullback. |
| Near resistance | $37.31 to $40 | The 52-week high of $37.31 is the immediate overhead level, with the analyst high target near $40 above it. A daily close above $37.31 would open the path toward new highs. |
| 50-day moving average | $33.03 | The intermediate trend band sits near $33.03. Price holding above this level keeps the short-term uptrend intact. |
| 200-day moving average | $29.62 | The long-term average is near $29.62 after the sustained rally. A break below this level would be a significant trend warning. |
| Momentum | RSI(14) near 58 | The Relative Strength Index of about 58 on August 3, 2026 is below the overbought threshold, giving room for momentum to re-accelerate after the mid-July pullback. |
| Volume | About 448,000 average daily shares | Average 20-day volume near 448,000 shares with short interest of about 1.9 million shares (1.9% of shares outstanding) provides adequate liquidity for the $3.5B market cap. |
| 52-week range | $21.01 to $37.31 | The wide range reflects the earnings recovery and re-rating story. HG is up about 69.5% over the trailing 52 weeks, so the reward-risk equation changes near the top of the band. |
| Invalidation | Close below $29.60 | A daily close below the 200-day moving average of $29.62 would weaken the long-term trend. A break below $33 would reduce short-term trend confidence first. |
HG AI trading strategy
The HG AI trading strategy is a rules-based research framework for a specialty insurer with strong ROE, low leverage, a new special dividend, and earnings-cycle risk. It is not personal advice and should be paired with live quotes, filings, position sizing, and risk controls, especially around the August 6, 2026 earnings date.
Look for HG to hold above the $33 to $35 support band and confirm a daily close above the $37.31 52-week high before adding to a long bias. Volume confirmation during a breakout above $37.31 adds conviction.
A daily close below $33 or a failed push at the 52-week high without fresh fundamental catalysts should reduce the short-term trend thesis.
If HG pulls back toward $33 to $35 without a negative underwriting surprise, catastrophe loss spike, or rating change, compare the entry price with trailing EPS, book value of $27.42, and free cash flow per share for relative value context.
Set a defined loss limit because reinsurance stocks can repriced quickly after earnings or loss events. Avoid averaging down without fresh data from the August 6, 2026 report.
Track gross premiums written, combined ratio, net investment income, book value per share, share count, catastrophe loss load, reserve development, and the progress of the $159 million remaining buyback authorization. Monitor competitors like RNR, EG, and SPNT for market pricing trends.
Reduce confidence if premium volume declines year over year, combined ratios deteriorate, the 2026 earnings forecast keeps dropping, or investment losses reduce book value growth.
Investment research summary
Hamilton Insurance Group underwrites specialty insurance and reinsurance through three platforms, earning profit from underwriting margins, investment income on the float, and fee-based services. Customers are other insurers, brokers, and corporate clients that need specialty risk capacity.
The moat is built on Bermuda regulatory standing, specialty underwriting expertise across casualty, property, and specialty lines, broker relationships, a low-leverage balance sheet, and an upgraded A (Excellent) AM Best rating for Hamilton Select. It is not as wide as larger peers because HG has a shorter operating history, smaller scale, and a narrower business line base that can be more exposed to individual market cycles.
The thesis can fail if HG underprices risks in a competitive market, suffers a large catastrophe or conflict loss that depletes reserves, loses key underwriters, over-expands into unfamiliar lines, or faces a soft market reversal that hurts both premium volume and investment income. The reverse check asks whether a 5.8x trailing P/E is pricing in an earnings decline that is not yet visible.
CEO Pina Albo founded the company in 2013, built three platforms from scratch, took HG public in 2023, and in early 2026 declared the first special dividend of $200 million, paid $2.00 per share in March, and repurchased shares. The capital allocation track record is still short as a public company. Key tests include disciplined growth in a softer market, continued buybacks, and whether team depth supports the company beyond the founder.
Specialty insurance and reinsurance benefit from rising insured values, climate-driven demand, and regulatory complexity that favors experienced underwriters. However, industry profitability is cyclical: record industry capital and manageable catastrophe losses pressured April 1 renewals, and management expects similar pricing pressure at the mid-year renewals, even though margins come off historically high levels.
At about 5.8x trailing earnings and 1.29x book value, HG prices in meaningful earnings cyclicality and a forecast earnings decline for full year 2026. The margin of safety depends on whether current ROE levels are sustainable and whether the market pays a higher multiple for consistent underwriting results. The three-year scenario framework suggests a base target near $40 and a bullish target near $48, broadly consistent with the analyst median target of $39.
Source-backed data
Every metric below includes a source and last verification date.
| Metric | Value | Source | Last verified |
|---|---|---|---|
| HG price | $35.48 intraday on August 3, 2026; prior close $35.96 | StockAnalysis.com HG quote (CBOE data) | August 3, 2026 |
| Market capitalization | $3.52 billion, verified as $35.48 x 99.27 million shares with 0.06% deviation | financial_rigor.py market cap verification | August 3, 2026 |
| Shares outstanding | Approximately 99.27 million shares, down 3.58% year over year | StockAnalysis.com share statistics | August 3, 2026 |
| TTM revenue | $2.89 billion; FY2025 revenue $2.91 billion, up 24.7% | StockAnalysis.com financials (Fiscal.ai and S&P data) | August 3, 2026 |
| TTM net income | $629 million, TTM diluted EPS $6.10; FY2025 net income $577 million, up 44% | StockAnalysis.com financials | August 3, 2026 |
| Margins and returns | Profit margin 21.7%, operating margin 30.3%, ROE 33.7% (reported), ROIC 29.9% | StockAnalysis.com statistics | August 3, 2026 |
| Cash and debt | Cash $1.29 billion, total debt $150 million, debt-to-equity about 5%, net cash $693 million or $6.98 per share | StockAnalysis.com balance sheet statistics | August 3, 2026 |
| Free cash flow | $908 million trailing, $9.15 per share | StockAnalysis.com cash flow statistics | August 3, 2026 |
| Enterprise Value | $2.84 billion, EV/EBITDA 3.17x, EV/FCF 3.12x | StockAnalysis.com statistics | August 3, 2026 |
| Valuation check | 5.82x P/E, 1.29x P/B, 1.19x P/S, 3.88x P/FCF, 17% earnings yield, 25.8% FCF yield | financial_rigor.py valuation verification | August 3, 2026 |
| Dividend and shareholder return | $2.00 special dividend paid March 2026 (5.6% yield), buyback yield 3.6%, shareholder yield 9.2% | StockAnalysis.com dividend history and Q1 2026 earnings call | August 3, 2026 |
| Technical snapshot | 52-week range $21.01 to $37.31; 50-day MA $33.03; 200-day MA $29.62; RSI about 58; 52-week price change +69.5% | StockAnalysis.com statistics | August 3, 2026 |
| Analyst consensus | 7 analysts, consensus Buy, average target $35.86, median $39, high $40 (Citizens, July 10, 2026) | StockAnalysis.com forecast and ratings | August 3, 2026 |
| Next earnings date | August 6, 2026, after market close | StockAnalysis.com and Business Wire | August 3, 2026 |
This HG AI stock analysis page is an informational research tool only. It is not investment advice, a rating, or a recommendation to buy or sell any security. Forecast scenarios are based on available data and explicit assumptions, and they can be wrong if underwriting, reserves, catastrophe or conflict losses, reinsurance pricing, investment markets, or market multiples change.
Design trading strategies visually with 10+ indicators. Set entry/exit conditions and risk management, then generate Pine Script code with no coding required.
Filter and discover stocks based on market cap, dividend yield, P/E ratio, sector, and more. Screen thousands of stocks with real-time data.
Smart AI-driven stock selection with fundamental screening, analyst estimates, and key metrics. Filter by P/E, market cap, dividends, and more.
